knowledge -WSS

knowledge

author：leisure time 2025-09-06 04:33:49 - browse：515

Brain cancer — Michelle Monje/Stanford University/NIH

Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

“We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Childhood cancer progress stalls for Black, Hispanic kids: Report

knowledge

WSS

Ransomware attacks on hospitals: Study outlines patient impact

Lindsay Lohan welcomes 1st child with husband Bader Shammas

In key trial, Verve's treatment lowers cholesterol levels in patients

Ebola public health emergency is over, WHO declares

Why some people catch Covid but never get sick

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

focus

knowledge

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Apple is now the first public company to be valued at $3 trillion

Does good food count as health care? Study aims to find out

Anesthesiologist group: stop taking Ozempic before surgery

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

In Memoriam: Notable people who died in 2023

Ransomware attacks on hospitals: Study outlines patient impact

Drug repurposing or repositioning? The language matters

Celebrate National Dole Whip Day for 3 days this week at Disney

focus

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

India sets sights on home

PBM reforms clear House panel

DOJ, FTC to increase scrutiny of all types of health care mergers

Ebola public health emergency is over, WHO declares

focus

knowledge

explore

explore